Madagascar vs Senegal: Treatment coverage for schistosomiasis
Madagascar
41.4%
in 2024
Senegal
39.7%
in 2024
Madagascar rank
26th
Senegal rank
29th
Treatment coverage for schistosomiasis over time
- Madagascar
- Senegal
How they compare
Madagascar currently reports 41.4% against 39.7% in Senegal, a difference of 1.7%.
The two have swapped places 2 times across 13 shared years of data; in 2009 it was Madagascar ahead.
Madagascar ranks 26th and Senegal ranks 29th of 45 countries.
Across the 3 decades both report, Madagascar averaged higher in 1 and Senegal in 2.
Head to head by decade
| Decade | Madagascar | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.3% | 3.3% | 1.9% | Madagascar |
| 2010s | 21.3% | 37.2% | 15.9% | Senegal |
| 2020s | 35.6% | 40.2% | 4.6% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Madagascar or Senegal?
- Madagascar, at 41.4% against 39.7% in Senegal as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Madagascar and Senegal?
- 1.7%, with Madagascar ahead.
- How many years of comparable data are there for Madagascar and Senegal?
- 13 years are reported by both, from 2009 to 2024.
- How do Madagascar and Senegal rank globally for treatment coverage for schistosomiasis?
- Madagascar ranks 26th and Senegal ranks 29th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.